Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial

Erameh C., Okwaraeke K., Kleist C., Edeawe O., Adedosu N., Ekata E., Abejegah C., Owhin S., Babatunde F., Omansen T., Meneguim A., Duvignaud A., Mischlinger J., Ithete N., Oestereich L., Hinzmann J., Ahmed L., Duraffour S., Eifedyi R., Okogbenin S., Akhideno P., Ayodeji OO., Günther S., Wicha SG., Jaspard M., Pahlmann M., Ramharter M., Groger M.

DOI

10.1038/s41591-026-04402-w

Type

Journal article

Publisher

Springer Science and Business Media LLC

Publication Date

2026-05-15T00:00:00+00:00

Permalink More information Close